Collegium Pharmaceutical | 4:持股變動聲明-高管 Kuhlmann Shirley R.
Collegium Pharmaceutical | 4:持股變動聲明-高管 Tupper Colleen
Collegium Pharmaceutical | 4:持股變動聲明-高管 Dreyer Scott
Collegium Pharmaceutical | 4:持股變動聲明-董事 SANTINI GINO
Collegium Pharmaceutical | 4:持股變動聲明-董事 Melincoff Gwen A
Collegium Pharmaceutical | 4:持股變動聲明-董事 McFarlane Neil F.
Collegium Pharmaceutical | 4:持股變動聲明-董事 Freund John Gordon
Collegium Pharmaceutical | 4:持股變動聲明-董事 Fallon John A.
Collegium Pharmaceutical | 4:持股變動聲明-董事 Balice-Gordon Rita J.
Collegium Pharmaceutical | 4:持股變動聲明-董事 Heffernan Michael Thomas
Collegium Pharmaceutical | 4:持股變動聲明-董事 BOHLIN GAREN G
Collegium Pharmaceutical | 4:持股變動聲明-高管 Smith Thomas B
Collegium Pharmaceutical | 4:持股變動聲明-高管 Dreyer Scott
Collegium Pharmaceutical | 4:持股變動聲明-高管 Smith Thomas B
Collegium Pharmaceutical | 4:持股變動聲明-高管 Dreyer Scott
Collegium Pharmaceutical | 4:持股變動聲明-高管 Kuhlmann Shirley R.
Collegium Pharmaceutical | 4:持股變動聲明-高管 Ciaffoni Joseph
Collegium Pharmaceutical | 4:持股變動聲明-高管 Tupper Colleen
Collegium Pharmaceutical | SC 13G/A:超過5%持股股東披露文件(修正)-Eventide Asset Management, LLC(8.07%),Finny Kuruvilla, M.D. Ph. D.(8.07%)等
Collegium Pharmaceutical | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(7.09%)
暫無數據